摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-cyclopropyl-6-fluoro-4-oxo-4,10-dihydro-1H-thieno-[2',3':4,5]pyrrolo[3,2-h]quinoline-3-carboxylic acid | 1247019-51-7

中文名称
——
中文别名
——
英文名称
1-cyclopropyl-6-fluoro-4-oxo-4,10-dihydro-1H-thieno-[2',3':4,5]pyrrolo[3,2-h]quinoline-3-carboxylic acid
英文别名
3-Cyclopropyl-9-fluoro-6-oxo-12-thia-3,16-diazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,4,7,9,11(15),13-hexaene-5-carboxylic acid
1-cyclopropyl-6-fluoro-4-oxo-4,10-dihydro-1H-thieno-[2',3':4,5]pyrrolo[3,2-h]quinoline-3-carboxylic acid化学式
CAS
1247019-51-7
化学式
C17H11FN2O3S
mdl
——
分子量
342.35
InChiKey
PHOLFMMCGGYQBF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.9
  • 重原子数:
    24
  • 可旋转键数:
    2
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    102
  • 氢给体数:
    2
  • 氢受体数:
    6

反应信息

  • 作为产物:
    描述:
    ethyl 1-cyclopropyl-6-fluoro-4-oxo-4,10-dihydro-1H-thieno[2',3':4,5]pyrrolo[3,2-h]quinoline-3-carboxylate 在 盐酸 作用下, 以 乙醇 为溶剂, 以91%的产率得到1-cyclopropyl-6-fluoro-4-oxo-4,10-dihydro-1H-thieno-[2',3':4,5]pyrrolo[3,2-h]quinoline-3-carboxylic acid
    参考文献:
    名称:
    Synthesis and biological evaluation of tetracyclic fluoroquinolones as antibacterial and anticancer agents
    摘要:
    A simple and efficient synthesis of 6-fluoro-4-oxopyrido[2,3-a] carbazole-3-carboxylic acids (13a-e) and a structurally related 6-fluoro-4-oxothieno[2 ',3 ': 4,5] pyrrolo[3,2-h] quinoline (13f) was achieved via Stille arylation of 7-chloro-6-fluoro-8-nitro-4-oxoquinoline-3-carboxylate and a subsequent microwave-assisted phosphite-mediated Cadogan reaction. The new compounds were tested for their in vitro antimicrobial and antiproliferative activity. The ability of 13a-f to inhibit the activity of DNA gyrase and topoisomerase IV was also investigated. The thieno isostere (13f) emerged as the most active antibacterial, while the 9-fluoro derivative (13e) was the most potent against multidrug-resistant staphylococci. Compounds 13a, 13c-f displayed growth inhibition against MCF-7 breast tumor and A549 non-small cell lung cancer cells coupled with an absence of cytotoxicity toward normal human-derm fibroblasts (HuDe). Compound 13e was the most active anticancer against MCF-7 cells, with greater potency than ellipticine (IC50 0.8 and 1.6 mu M, respectively). The most active compounds in this series show promise as dual acting anticancer and antibacterial chemotherapeutics. (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2010.06.098
点击查看最新优质反应信息

文献信息

  • Synthesis and biological evaluation of tetracyclic fluoroquinolones as antibacterial and anticancer agents
    作者:Salah A. Al-Trawneh、Jalal A. Zahra、Marwan R. Kamal、Mustafa M. El-Abadelah、Franca Zani、Matteo Incerti、Andrea Cavazzoni、Roberta R. Alfieri、Pier G. Petronini、Paola Vicini
    DOI:10.1016/j.bmc.2010.06.098
    日期:2010.8
    A simple and efficient synthesis of 6-fluoro-4-oxopyrido[2,3-a] carbazole-3-carboxylic acids (13a-e) and a structurally related 6-fluoro-4-oxothieno[2 ',3 ': 4,5] pyrrolo[3,2-h] quinoline (13f) was achieved via Stille arylation of 7-chloro-6-fluoro-8-nitro-4-oxoquinoline-3-carboxylate and a subsequent microwave-assisted phosphite-mediated Cadogan reaction. The new compounds were tested for their in vitro antimicrobial and antiproliferative activity. The ability of 13a-f to inhibit the activity of DNA gyrase and topoisomerase IV was also investigated. The thieno isostere (13f) emerged as the most active antibacterial, while the 9-fluoro derivative (13e) was the most potent against multidrug-resistant staphylococci. Compounds 13a, 13c-f displayed growth inhibition against MCF-7 breast tumor and A549 non-small cell lung cancer cells coupled with an absence of cytotoxicity toward normal human-derm fibroblasts (HuDe). Compound 13e was the most active anticancer against MCF-7 cells, with greater potency than ellipticine (IC50 0.8 and 1.6 mu M, respectively). The most active compounds in this series show promise as dual acting anticancer and antibacterial chemotherapeutics. (C) 2010 Elsevier Ltd. All rights reserved.
查看更多